Atlas Venture
Portfolio companies
Atlas Venture is on record against 27 companies.
AAVantgarde Bio
Accent Therapeutics
Actelion
Adnexus Therapeutics
Affinia Therapeutics
Aiolos Bio
Akero Therapeutics
Alnylam Pharmaceuticals
Annovation Biopharma
Antares Therapeutics
Arkuda Therapeutics
ArQule
Arteaus Therapeutics
Avila Therapeutics
Bicycle Therapeutics
Cadent Therapeutics
Caldera Therapeutics
Cogent Biosciences
Comanche Biopharma
CoStim Pharmaceuticals
Crucell
Day One Biopharmaceuticals
deCODE genetics
Delinia
Diagonal Therapeutics
Disarm Therapeutics
Disc Medicine
Geography
Cambridge Ma, North America
Investment focus
Atlas Venture invests at the early stage (seed and Series A) in sectors including enterprise software, life sciences, and technology. The firm is based in Cambridge, MA, with a primary geographic focus on the United States.
Related investors
- GVAlso backs Affinia Therapeutics and Accent Therapeutics
- Google VenturesAlso backs Affinia Therapeutics and Accent Therapeutics
- F-Prime Capital (fka Fidelity Biosciences)Also backs Affinia Therapeutics
- Vertex HoldingsAlso backs Bicycle Therapeutics
- Abstract VenturesAlso invests at the seed and Series A stages
Get a deep full report on Atlas Venture →
Get warm-intro paths to Atlas Venture →
See how VCs use MentionFox →
Public profile · MentionFox — investor research, warm-intro mapping, and full reports.